Skip to main content

Table 1 Characteristics of studies included in review, 2014-2019

From: Risk factors for fecal carriage of drug-resistant Escherichia coli: a systematic review and meta-analysis

Author, year

Country

Study population

Study design

Study period

Sample size

Pathogen type

Arcilla 2017

Netherlands

Travellers

Prospective cohort study

2012 Nov - 2013 Nov

1847

ESBL-PE, CPE

Angelin 2015

Sweden

Travellers

Prospective study

2010 Apr - 2014 Jan

99

E. coli

Caudell 2018*

Tanzania

General adult

Prospective study

2012 Mar - 2015 Jul

226*

E. coli

Dohmen 2017

Netherlands

Employees in a pig slaughterhouse

Prospective study

2015 Jun

334

E. coli

Dohmen 2017*

Netherlands

Pig farmers, family members and employees

Longitudinal study

2011 Mar - 2011 Oct

146

ESBL-PE

Lubbert 2015

Germany

Travellers

Prospective cohort study

2013 May - 2014 Apr

191

ESBL-PE

McNulty 2018

England

General adult

Retrospective cohort study

2013 - 2014

2430

ESBL-PE

Miranda 2016

Germany

Travellers

Retrospective study

2013 Feb - 2014 Apr

211

ESBL-PE

Mo 2019

Singapore

General adult

Cross sectional study

2016 Jun - 2017 Apr

305

ESBL-PE

Reuland 2016

Netherlands

General adult

Case control study

2011 Jun - 2011 Nov

1695

ESBL-PE

Reuland 2015

Netherlands

General adult

Case control study

2011 Aug - 2011 Dec

550

pAmpC producing E. coli

Ruh 2019

Northern Cyprus

General adult

Retrospective cohort study

2017 Sep - 2017 Dec

500

Enterobacteriaceae

Sanneh 2018*

Gambia

Food handlers

Cross sectional study

2015 Jul - 2015 Sep

565

Enterobacteriaceae

Vading 2016

Sweden

Travellers

Prospective cohort study

2013 Apr - 2015 May

175

ESBL E. coli

Wielders 2017

Netherlands

General adult

Cross sectional study

2012 Nov

2432

ESBL-PE

  1. Note: ** not included in meta-analysis. *indicates sample size was households (all others are individuals). ESBL-PE = Extended-spectrum beta-lactamase producing Enterobacteriaceae; CPE = Carbapenemase-producing Enterobacteriaceae